Literature DB >> 15377584

Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication.

M Stotz1, D Thümmler, M Schürch, J-C Renggli, A Urwyler, H Pargger.   

Abstract

Neuroleptic malignant syndrome is a rare complication when using neuroleptic drugs. We report the case of a patient with severe Parkinson's disease who developed neuroleptic malignant syndrome after withdrawal of his antiParkinsonian medication for elective coronary artery bypass grafting. Sodium dantrolene may be a therapeutic option in severe cases.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15377584     DOI： 10.1093/bja/aeh269

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


  8 in total

Review 1.  Parkinsonism-Hyperpyrexia Syndrome and Dyskinesia-Hyperpyrexia Syndrome in Parkinson's Disease: Two Cases and Literature Review.

Authors:  Jian-Yong Wang; Jie-Fan Huang; Shi-Guo Zhu; Shi-Shi Huang; Rong-Pei Liu; Bei-Lei Hu; Jian-Hong Zhu; Xiong Zhang
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

2.  Acute Akinesia, an unusual complication in Parkinson's Disease: a case report.

Authors:  Marco Simonetto; Laura Ferigo; Luca Zanet; Livio Capus; Lucia Antonutti; Marino Zorzon; Gilberto Pizzolato
Journal:  Neurol Sci       Date:  2008-07-09       Impact factor: 3.307

Review 3.  Clinical problems in the hospitalized Parkinson's disease patient: systematic review.

Authors:  Oliver H H Gerlach; Ania Winogrodzka; Wim E J Weber
Journal:  Mov Disord       Date:  2011-01-31       Impact factor: 10.338

4.  A case of malignant hyperthermia that was difficult to be differentiated from oral antipsychotic polypharmacy-associated neuroleptic malignant syndrome.

Authors:  Yoshiki Hara; Yutaka Hosoya; Ryo Deguchi; Shigehito Sawamura
Journal:  JA Clin Rep       Date:  2016-06-02

5.  Widening spectrum of neuroleptic malignant syndrome: Case series.

Authors:  Gunchan Paul; Sachi Singhal; Birinder S Paul; Gurparvesh Singh; Shriya Goyal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2021-10-11

6.  Malignant syndrome in Parkinson's disease without dopaminergic drug withdrawal.

Authors:  C J Suresh Chandran
Journal:  Ann Indian Acad Neurol       Date:  2008-10       Impact factor: 1.383

7.  Two unusual complications of neuroleptic malignant syndrome.

Authors:  A Ahmad; C A Harrison; H G Davies
Journal:  Indian J Crit Care Med       Date:  2013-03

Review 8.  Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective.

Authors:  Lurdes Tse; Alasdair M Barr; Vanessa Scarapicchia; Fidel Vila-Rodriguez
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.